Pawel Buszman1*, MD, FACC, FSCAI; Iwona Szkróbka, MD1; Zofia Tendera, MD1; Agata Gruszka1, MD; Bozena Bialkowska1, MD; Radoslaw Parma1, MD; Wojciech Wojakowski1, MD; Marek Król1; Stefan R. Kiesz3, MD, FACC; Andrzej Bochenek2, MD; Michal Tendera1, MD, FESC, FACC
1. 3rd Division of Cardiology and Acute Coronary Care Unit, Silesian School of Medicine, Katowice, Poland; 2. 1st Division of Cardiac Surgery, Silesian School of Medicine, Katowice, Poland; 3. American Heart of Poland, Ustron, Poland
Aims: REvascularization in Ischaemic HEart Failure Trial (REHEAT) is a registry prospectively evaluating the outcomes of percutaneous myocardial revascularization in postinfarction patients